New eye drop aims to zap dry eye discomfort in weeks

NCT ID NCT07268599

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Acoltremon 0.003% eye drops can quickly relieve symptoms like burning, irritation, and blurriness in people with moderate-to-severe dry eye disease. Fifty adults will use the drops as directed and report their symptom changes over 28 days. The goal is to see how fast and effectively the treatment eases discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Acoltremon 0.003% eye drops

What this could lead to

If successful, this could offer a fast-acting option to ease dry eye symptoms like burning, irritation, and blurriness.

What could go wrong

This is a small, early-phase trial with only 50 participants and no placebo group, so results may not be conclusive or widely applicable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Colvard-Kandavel Eye Center

    Encino, California, 91316, United States